The Future Gold
Standard in
Newrotex develops innovative silk-based medical
solutions for the nervous system.
Newrotex develops innovative silk-based medical
solutions for the nervous system.
The answer to “Can you repair nerves?” shouldn’t come with caveats. This is why Newrotex is set to disrupt existing approaches to surgical nerve repair. We’re on track to provide an alternative to autografts, the current gold standard in treatment for nerve injuries. A gold standard that requires sacrificing a healthy nerve from another part of the body. With our patented silk-based technology, we’ll deliver an off-the-shelf solution for surgical repair of the nerve. Without the need for long, complicated operations or using expensive donor tissues, Newrotex makes immediate treatment possible for patients who have suffered nerve injuries due to trauma, medical conditions, or surgical treatments.
Annual operations for nerve injuries
Newrotex silk-based nerve products address the shortcomings of the solutions currently available.
Most of the world’s 1.5 million annual operations for nerve injuries are treated with autografts requiring a second injury and long surgery times, along with risking donor site morbidity and infection.
All of the major current solutions – autografts, allografts, and hollow tube conduits – are limited when repairing large gaps in nerves. Read Current Approaches for more about these and other shortcomings with current solutions for peripheral nerve repair.
Over the past few decades, the potential biomedical applications of silk have been gaining interest at an exponential rate.
The versatility created by silk’s chemical structure allows for the production of fibres, gels, scaffolds, films, membranes, and powders. Silk has shown to have excellent cell affinity, and being biocompatible, with the ability to tailor biodegradation, silk is an ideal candidate for biomedical applications.
In terms of nerve repair, luminal silk fibres inside a vein or conduit guide regenerating axons, while the bioabsorbable, permeable tube allows nutrients to support nerve regeneration. Furthermore, silk products can be stored at room temperature, thereby removing the need for expensive cold storage and transportation.
Our first product is a 10cm implant made from bundles of luminal spider silk fibres that can be implanted into a vein or inserted into hollow conduits to support nerve re-growth. Pre-clinical studies have show that SilkAxons® support superior axonal regeneration.
Our second product is an off-the-shelf silk-based peripheral nerve conduit pre-filled with enhancing luminal silk fibres, negating the need to use a vein.
The fibres have proven nerve-regenerating properties and clinical trials show them to be comparable or superior to autografts. And with a porous tubular biocompatible sheath designed to encourage vascularisation, we provide a new and better approach to treating patients with peripheral nerve injuries.
Newrotex launched a first-in-human clinical trial in Q3 2025 using SilkAxons® to bridge large nerve gaps of up to 10cm (significantly more than current FDA approved devices). This study will generate foundational data for Newrotex’s global clinical strategy. Our goal is to commence a large study this year culminating in an application for market approval in the USA and UK. We are also developing collaborations in which our silk platform technology may lead to further improvements in patient care, such as Schwann cell delivery and spinal cord injury repair.
Decades later, director brought the story back to the big screen with a modern cast.
Slapstick and situational comedy subplots designed to break the tension of the heavy melodrama.
: While sharing a similar name, this 2016 drama is a separate production focused on different themes. Sujatha Sinhala Film
While Sujatha was an unprecedented commercial juggernaut that broke box-office records across the island, it also drew sharp criticism from cultural purists and nationalists. Critics argued that the film was "foreign" in its DNA, noting that the characters behaved more like South Indians than Sinhalese, and that the landscapes, dances, and music lacked authentic local flavor.
Released in the nascent days of Sri Lankan cinema, the is not merely a movie; it is a milestone. It stands as a pivotal moment, shifting the industry from stage-influenced drama towards a more polished, commercial cinematic formula. Released on June 26, 1953 , Sujatha is arguably the first massive box-office hit in Sri Lankan history, paving the way for the "star system". Decades later, director brought the story back to
The film also featured music and songs that became immense hits, strengthening its popularity among the masses. 3. The Storyline (Plot Summary)
In conclusion, Sujatha is a cornerstone of Sinhala cinema. It was the film that proved the medium's power as a primary source of entertainment for the nation. While it relied heavily on Indian melodies and melodramatic structures, it successfully translated those elements into a local context that felt personal to the Sri Lankan audience. It remains a fascinating study of a nascent industry finding its footing, balancing the pressures of commercial viability with the slow emergence of a unique national voice. The echoes of Sujatha can still be heard in the music and seen in the dramatic beats of Sri Lankan teledramas and commercial films today, cementing its place as an immortal classic. AI responses may include mistakes. Learn more It stands as a pivotal moment, shifting the
In the history of Sri Lankan cinema, few films hold as much historical and cultural significance as Sujatha (1953). Released during the formative years of the local film industry, Sujatha was not merely a commercial success; it was a phenomenon that redefined public entertainment in Ceylon (now Sri Lanka). It served as a crucial bridge between South Indian cinematic formulas and the evolving identity of Sinhala cinema, leaving a permanent mark on generations of filmmakers and moviegoers.
The cast included: